A

Alexion

Global biopharmaceuticals focusing on rare diseases

Biostatistics Intern

Quantitative Biology & BiostatisticsPosted on Nov 12
Internship · Summer 2027Boston, MA, USA$48 /hr

About the Job

Requirements

  • Currently pursuing a PhD in Biostatistics, Statistics, or Mathematics.
  • Meet the graduation timeline requirement, with an anticipated graduation date after August 2027.
  • Have U.S. work authorization at application time that does not require future sponsorship; OPT support will not be provided.
  • Have basic knowledge of adaptive design in clinical trials.
  • Be familiar with statistical simulations and demonstrate the ability to conduct independent statistical research.
  • Have proficient programming skills in R and SAS and working experience using AI tools.
  • Have excellent writing, communication, and interpersonal skills.
  • Be able to report on site to Boston-Seaport, Massachusetts, three days per week; relocation assistance is not provided.

Responsibilities

  • Use AI tools to develop a statistical application.
  • Conduct a comprehensive simulation study to evaluate design characteristics and discuss results under varying assumptions.
  • Present the internship work at a departmental seminar and write a final report of the entire internship project.

About the Company

Alexion

Global biopharmaceuticals focusing on rare diseases

Alexion, now the rare disease group within AstraZeneca, develops and sells therapies for rare and ultra-rare diseases by targeting the complement immune system. Its drugs, such as Soliris and Ultomiris, inhibit the C5 component to slow or stop disease processes, while Strensiq and Kanuma address specific metabolic disorders. It differentiates itself through a deep focus on complement biology, pursuing first- or best-in-class therapies, and using a strategy that blends internal R&D with acquisitions to expand its pipeline. Its goal is to improve outcomes for patients with rare diseases and bring these therapies to a broader international market using AstraZeneca’s scale and capabilities.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Boston, MA
Founded
1992

Recently Posted Jobs

Explore more opportunities at Alexion

See more jobs